Talphera (TLPH) Other Non-Current Liabilities (2010 - 2026)
Talphera (TLPH) recorded quarterly Other Non-Current Liabilities of $1.2 million in Q1 2026, down 51.47% quarter-over-quarter from $2.4 million in Q4 2025, and up 31.02% on a YoY basis from $880000.0 in Q1 2025.
Talphera (TLPH) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends
Talphera's Other Non-Current Liabilities history runs 17 years deep, the most recent figure standing at $1.2 million for Q1 2026.
- In Q1 2026, Other Non-Current Liabilities rose 31.02% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $1.2 million (up 31.02% YoY), while the FY2025 annual figure was $2.4 million, up 123.94% from the prior year.
- Other Non-Current Liabilities was $1.2 million for Q1 2026 at Talphera, down from $2.4 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $84.6 million in Q1 2022 to a low of $759000.0 in Q2 2025.
- Historically, Other Non-Current Liabilities has averaged $7.1 million across 5 years, with a median of $1.8 million in 2023.
- Biggest YoY gain for Other Non-Current Liabilities was 46648.62% in 2022; the steepest drop was 99.04% in 2022.
- A 5-year view of Other Non-Current Liabilities shows it stood at $7.1 million in 2022, then sank by 74.95% to $1.8 million in 2023, then tumbled by 40.33% to $1.1 million in 2024, then surged by 123.94% to $2.4 million in 2025, then slumped by 51.47% to $1.2 million in 2026.
- The last three Other Non-Current Liabilities figures came in at $1.2 million (Q1 2026), $2.4 million (Q4 2025), and $1.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Talphera | 56.42 Mn | 56.42 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.15 Mn |
| Dec 31, 2025 | 2.38 Mn |
| Sep 30, 2025 | 1.85 Mn |
| Jun 30, 2025 | 759,000.00 |
| Mar 31, 2025 | 880,000.00 |
| Dec 31, 2024 | 1.06 Mn |
| Sep 30, 2024 | 2.08 Mn |
| Jun 30, 2024 | 2.33 Mn |
| Mar 31, 2024 | 2.78 Mn |
| Dec 31, 2023 | 1.78 Mn |
| Sep 30, 2023 | 1.38 Mn |
| Mar 31, 2023 | 1.79 Mn |
| Dec 31, 2022 | 7.10 Mn |
| Sep 30, 2022 | 827,000.00 |
| Jun 30, 2022 | 849,000.00 |
| Mar 31, 2022 | 84.62 Mn |
| Dec 31, 2021 | 85.29 Mn |
| Sep 30, 2021 | 85.98 Mn |
| Jun 30, 2021 | 128,000.00 |
| Mar 31, 2021 | 181,000.00 |